id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-D-0269-0113,FDA,FDA-2016-D-0269,"Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry",Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2024-11-12T06:18:06Z,,1,0,090000648243ddab
FDA-2016-D-0269-0112,FDA,FDA-2016-D-0269,"Prescription Requirement Under Section 503A of the Federal Food,
Drug, and Cosmetic Act; Guidance for Industry; Availability",Notice,Notice of Availability,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T14:33:49Z,2016-31607,0,0,090000648243d35a
FDA-2016-D-0269-0001,FDA,FDA-2016-D-0269,"Prescription Requirement Under Section 503A of the Federal Food, 
Drug, and Cosmetic Act; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2016-04-18T04:00:00Z,2016,4,2016-04-18T04:00:00Z,2016-07-19T03:59:59Z,2018-03-24T01:03:22Z,2016-08877,0,0,0900006481f700f7
FDA-2016-D-0269-0002,FDA,FDA-2016-D-0269,"Draft Guidance for Industry Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act",Other,Guidance,2016-04-18T04:00:00Z,2016,4,2016-04-18T04:00:00Z,,2020-07-01T02:20:38Z,,0,0,0900006481f704dd